Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Carcinoma, Non-Small-Cell Lung 149Squamous Cell Carcinoma of Head and Neck 76Head and Neck Neoplasms 75Stomach Neoplasms 52Lung Neoplasms 52Esophageal Neoplasms 34Neoplasms 33Uterine Cervical Neoplasms 32Urinary Bladder Neoplasms 32Carcinoma, Squamous Cell 27Parkinson Disease 4, Autosomal Dominant Lewy Body 26Neoplasm Metastasis 26Small Cell Lung Carcinoma 23Breast Neoplasms 23Cholangiocarcinoma 21Carcinoma 19Ovarian Neoplasms 14Adenocarcinoma Of Esophagus 14Triple Negative Breast Neoplasms 13Pancreatic Neoplasms 13Oropharyngeal Neoplasms 13Mesothelioma, Malignant 13Adenocarcinoma 13Biliary Tract Neoplasms 12Mesothelioma 11Gallbladder Neoplasms 11Esophageal Squamous Cell Carcinoma 10Carcinoma, Transitional Cell 10Tongue Neoplasms 9Laryngeal Neoplasms 9

Interventions

Cetuximab 4Radiosurgery 3Nivolumab 3Ipilimumab 3pembrolizumab 2Vorinostat 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Magnetic Resonance Spectroscopy 2Lapatinib 2Dasatinib 2Cisplatin 2CTLA-4 Antigen 2Bevacizumab 2temsirolimus 1ispinesib 1eribulin 1dehydroftorafur 1apalutamide 1amivantamab 1alectinib 1Specimen Handling 1Sorafenib 1Sirolimus 1Platinum 1Pilocarpine 1Pemetrexed 1Oral Hygiene 1NVP-BKM120 1Moxibustion 1MK 2206 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Salivary Gland Neoplasms × Cisplatin × Clear all
NCT00588770 2026-05-29

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
403 enrolled 10 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT00639769 2012-09-14

Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Vanderbilt-Ingram Cancer Center

Phase 2 Completed
41 enrolled 8 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡